Abbonarsi

Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency - 09/01/21

Doi : 10.1016/j.jaci.2020.04.033 
Maria Carmina Castiello, PhD a, b, , Marita Bosticardo, PhD c, , Nicolò Sacchetti, PhD a, Enrica Calzoni, MD a, c, Elena Fontana, PhD b, d, Yasuhiro Yamazaki, MD, PhD c, Elena Draghici, BS a, Cristina Corsino c, Ileana Bortolomai, PhD a, Lucia Sereni, PhD a, Hsin-Hui Yu, MD, PhD c, Paolo Uva, PhD e, Rahul Palchaudhuri, PhD f, g, h, David T. Scadden, MD f, g, Anna Villa, MD a, b, , Luigi D. Notarangelo, MD c,
a San Raffaele Telethon Institute for Gene Therapy SR-Tiget, IRCCS San Raffaele Scientific Institute, Milan, Cagliari, Italy 
b Institute of Genetic and Biomedical Research Milan Unit, National Research Council, Milan, Cagliari, Italy 
c Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md 
d Human Genome Lab, Humanitas Clinical and Research Center, Milan, Cagliari, Italy 
e CRS4, Science and Technology Park Polaris, Pula, Cagliari, Italy 
f Department of Stem Cell and Regenerative Biology, Harvard University, Harvard Stem Cell Institute, Cambridge, Mass 
g Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Mass 
h Magenta Therapeutics, Cambridge, Mass 

Corresponding author: Anna Villa, MD, SR-Tiget, Via Olgettina 58, Milan, 20127, Italy.SR-TigetVia Olgettina 58Milan20127Italy∗∗Luigi D. Notarangelo, MD, Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10, Room 5-3950, 10 Center Drive, Bethesda, MD 20892.Immune Deficiency Genetics SectionLaboratory of Clinical Immunology and MicrobiologyNational Institute of Allergy and Infectious DiseasesNational Institutes of HealthBuilding 10Room 5-395010 Center DriveBethesdaMD20892

Abstract

Background

Mutations in the recombinase-activating genes cause severe immunodeficiency, with a spectrum of phenotypes ranging from severe combined immunodeficiency to immune dysregulation. Hematopoietic stem cell transplantation is the only curative option, but a high risk of graft failure and poor immune reconstitution have been observed in the absence of myeloablation.

Objectives

Our aim was to improve multilineage engraftment; we tested nongenotoxic conditioning with anti-CD45 mAbs conjugated with saporin CD45 (CD45-SAP).

Methods

Rag1-KO and Rag1-F971L mice, which represent models of severe combined immune deficiency and combined immune deficiency with immune dysregulation, respectively, were conditioned with CD45-SAP, CD45-SAP plus 2 Gy of total body irradiation (TBI), 2 Gy of TBI, 8 Gy of TBI, or no conditioning and treated by using transplantation with lineage-negative bone marrow cells from wild-type mice. Flow cytometry and immunohistochemistry were used to assess engraftment and immune reconstitution. Antibody responses to 2,4,6-trinitrophenyl–conjugated keyhole limpet hemocyanin were measured by ELISA, and presence of autoantibody was detected by microarray.

Results

Conditioning with CD45-SAP enabled high levels of multilineage engraftment in both Rag1 mutant models, allowed overcoming of B- and T-cell differentiation blocks and thymic epithelial cell defects, and induced robust cellular and humoral immunity in the periphery.

Conclusions

Conditioning with CD45-SAP allows multilineage engraftment and robust immune reconstitution in mice with either null or hypomorphic Rag mutations while preserving thymic epithelial cell homeostasis.

Il testo completo di questo articolo è disponibile in PDF.

Graphical abstract




Il testo completo di questo articolo è disponibile in PDF.

Key words : RAG deficiency, conditioning, anti-CD45–saporin, immunotoxin, engraftment, immune reconstitution, hematopoietic stem cell transplantation, thymic epithelial cells

Abbreviations used : ADC, BM, CD45-SAP, CID-ID, DN, HSC, HSCT, HSPC, Lin, LSK, mTEC, MZ, PB, RAG, SCID, TBI, TEC, TNP, WBC, WT


Mappa


 Supported by a grant from the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (to L.D.N.); the National Institutes of Health Bench to Bedside grant RAG Deficiency: From Pathophysiology to Precise Gene Editing (to L.D.N. and A.V.); and grants Tiget E2 (to A.V.), Italian Ministry of Health PE-2016-02363691 (to E.F. and L.D.N.), EU2020 (SCIDNET) No. 666908 (to A.V.), and MIUR 2017-5XHBPN (to A.V.).
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


© 2020  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 147 - N° 1

P. 309 - Gennaio 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Accuracy of penicillin allergy diagnostic tests: A systematic review and meta-analysis
  • Bernardo Sousa-Pinto, Isabel Tarrio, Kimberly G. Blumenthal, Luís Araújo, Luís Filipe Azevedo, Luís Delgado, João Almeida Fonseca
| Articolo seguente Articolo seguente
  • Cow’s milk protein ?-lactoglobulin confers resilience against allergy by targeting complexed iron into immune cells
  • Franziska Roth-Walter, Sheriene Moussa Afify, Luis F. Pacios, Bart R. Blokhuis, Frank Redegeld, Andreas Regner, Lisa-Marie Petje, Alessandro Fiocchi, Eva Untersmayr, Zdenek Dvorak, Karin Hufnagl, Isabella Pali-Schöll, Erika Jensen-Jarolim

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.